| Literature DB >> 28345136 |
Yucheng Yan1, Sylvia Ramirez2, Shuchi Anand3, Jiaqi Qian4, Li Zuo5.
Abstract
Cumulative evidence indicates it may be worthwhile revisiting the twice-weekly hemodialysis (HD) regimen as a valid option for individualized or incremental treatments for selected patients with end-stage renal disease. In this article, we will review the current evidences on the potential pros and cons of twice-weekly HD compared to thrice-weekly HD including China's experience in the practice of twice-weekly HD. A prudent patient selection and close dialysis adequacy monitoring might be necessary for this medical treatment choice. More randomized prospective controlled studies for the critical evaluation of twice-weekly dialysis are encouraged.Entities:
Mesh:
Year: 2017 PMID: 28345136 PMCID: PMC5545085 DOI: 10.1111/sdi.12588
Source DB: PubMed Journal: Semin Dial ISSN: 0894-0959 Impact factor: 3.455